LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH): The inclusion of gefitinib tablets for the first-line treatment of EGFRPACC mutations in NSCLC as a breakthrough therapy candidate has been announced.
Shareholders of Shenyang Fortune Precision Equipment (688409.SH) intend to inquire about transferring 3% of the company's shares.
Selected A-share announcements | 9 consecutive boards Senton Energy (001331.SZ) highlights risks.
Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH): The inclusion of gefitinib tablets for the first-line treatment of EGFRPACC mutations in NSCLC as a breakthrough therapy candidate has been announced.
Shareholders of Shenyang Fortune Precision Equipment (688409.SH) intend to inquire about transferring 3% of the company's shares.
Selected A-share announcements | 9 consecutive boards Senton Energy (001331.SZ) highlights risks.
RECOMMEND
